Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LATS2 encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. Additionally we are shipping and many more products for this protein.
Showing 10 out of 89 products:
Human Polyclonal LATS2 Primary Antibody for IP, PLA - ABIN152335
Kilili, Kyriakis et al.: Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 ... in The Journal of biological chemistry 2010
Show all 14 references for ABIN152335
Mouse (Murine) Polyclonal LATS2 Primary Antibody for WB - ABIN1881491
Oh, Lee, Kim, Kim, Oh, Hwang, Kong, Kwon, Lim: Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. in Molecular and cellular biology 2009
Show all 4 references for ABIN1881491
Human Polyclonal LATS2 Primary Antibody for IF, IHC - ABIN1534144
Hori, Takaori-Kondo, Kamikubo, Uchiyama: Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor. in Oncogene 2000
Show all 3 references for ABIN1534144
Human Polyclonal LATS2 Primary Antibody for IHC (p), WB - ABIN391034
Blume-Jensen, Hunter: Oncogenic kinase signalling. in Nature 2001
Human Polyclonal LATS2 Primary Antibody for EIA, IHC (p) - ABIN359092
Cantrell: Phosphoinositide 3-kinase signalling pathways. in Journal of cell science 2001
Study demonstrates that, in 3 different murine syngeneic tumor models (B16, SCC7, and 4T1), loss of the Hippo pathway kinases LATS1 (show LATS1 Antibodies)/2 (large tumor suppressor (show LATS1 Antibodies) 1 and 2) in tumor cells inhibits tumor growth; data indicate a new paradigm for how tumor immunogenicity is regulated through the Hippo signaling pathway in tumor cells.
mice harboring liver-specific Lats2 conditional knockout (Lats2-CKO) displayed constitutive SREBP activation and overexpressed SREBP target genes and developed spontaneous fatty liver disease
protein and mRNA expression of the MST1 (show MST1 Antibodies) and LATS2 were decreased significantly as mouse age increased (p < 0.05), however, the mRNA expression of them increased significantly in 16 m compared with 5 m as well as the protein expression of LATS2.
Lats2 is recruited to the p53 (show TP53 Antibodies) pathway to coordinate proper transcriptional reprogramming.
Lats2 regulates the balance between proliferation and differentiation during adipose development.
miR (show MLXIP Antibodies)-302a plays a critical role in mediating the effects of folate on cell proliferation and cell cycle-specific apoptosis by targeting Lats2 gene.
KIBRA (show WWC1 Antibodies) associates with and activates Lats (large tumor suppressor (show LATS1 Antibodies)) 1 and 2 kinases by stimulating their phosphorylation on the hydrophobic motif
Lats2 plays an essential mitotic role in coordinating accurate cytokinesis completion, governing the stabilization of other mitotic regulators
Lats2 affects both growth and death of cardiac myocytes, but it primarily regulates the size of the heart and acts as an endogenous negative regulator of cardiac hypertrophy.
findings reveal a non-canonical (that is, YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies)-independent) effect of LATS (show LATS1 Antibodies) in the regulation of human breast cell fate
LATS2 as the direct target of miR (show MLXIP Antibodies)-372 in prostate cancer cells.
Data suggest that, at least using the commercial antibodies used in this study, immunohistochemical staining for NF2 (neurofibromin 2 (show NF2 Antibodies)), LATS2 (large tumor suppressor (show LATS1 Antibodies) kinase 2), and YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies) (nuclear translocation of complex of Yes-associated protein [YAP (show YAP1 Antibodies)] with transcriptional coactivator with PDZ-binding motif (show WWTR1 Antibodies) [TAZ (show TAZ Antibodies)]) is not helpful for differential diagnosis of mesothelioma versus a benign proliferation.
overexpression of LATS2 resulted in mobility inhibition in non-small cell lung cancer cell lines A549 and H1299, and reduced protein level of matrix metalloproteinase-2 (MMP-2 (show MMP2 Antibodies)) and MMP-9 (show MMP9 Antibodies).
LATS2 was found to have binding sites for miR (show MLXIP Antibodies)-135b in the 3'UTR (show UTS2R Antibodies) region and results demonstrated that LATS2 is a direct target of miR (show MLXIP Antibodies)-135b which regulates its expression in breast cancer cells.
Characterisation of LATS2 variants uncovers novel insights into the regulation of LATS (show LATS1 Antibodies) kinases in Hippo signalling.
LATS2 could be induced by TNF-alpha (show TNF Antibodies) and inhibited cell proliferation and invasion by phosphorylating YAP (show YAP1 Antibodies) in OSCC cells.
our current data indicated a new regulatory mechanism of YAP1 (show YAP1 Antibodies) by the LATS2-mediated phosphorylation that was involved in hepatocellular carcinoma tumorigenesis.
Mutation in LATS2 gene is associated with malignant peritoneal mesothelioma.
Phosphorylation of CHO1 (show KIF23 Antibodies) at S716 by Lats2 regulate its centrosomal localization, and that phosphorylated CHO1 (show KIF23 Antibodies) interacts with and activates LIMK1 (show LIMK1 Antibodies) during early mitosis.
Thus AMOT (show AMOT Antibodies) is a direct substrate of Lats1 (show LATS1 Antibodies)/2 mediating functions of the Hippo pathway in endothelial cell migration and angiogenesis.
lats (show LATS1 Antibodies) genes show distinctly different expression profiles during gastrulation. lats1 (show LATS1 Antibodies) is almost ubiquitously expressed through development, and lats2 is more prominently expressed in the non-neural ectoderm region of zebrafish gastrula.
The lats2 exhibit inverted expression to YAP1 (show YAP1 Antibodies), another member of the Hippo pathway which positively regulates cell growth and proliferation, during the differentiation of 3T3-L1 preadipocytes.
This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression.
kinase phosphorylated during mitosis protein
, large tumor suppressor homolog 2
, serine/threonine-protein kinase LATS2
, serine/threonine-protein kinase kpm
, large tumor suppressor, homolog 2
, LATS (large tumor suppressor, Drosophila) homolog 2
, LATS, large tumor suppressor, homolog 2
, serine/threonine kinase KPM
, warts-like kinase
, large tumor suppressor 2-like protein